Wellnex Life Limited (ASX:WNX) Reports 46% Revenue Growth and AIM Listing
Financial Performance
Wellnex Life Limited reported revenue of $8.0 million for the January to April 2025 period, a 46% increase compared to $5.4 million in the same period last year. Gross margins rose by 55% to $2.99 million from $1.93 million in the prior year period. In April 2025 alone, revenue surged by 75% to $2.57 million, with gross margins increasing 74% to $1.13 million from $0.48 million in April 2024.
AIM Market Listing
Wellnex successfully listed on the AIM Market of the London Stock Exchange on March 21, 2025. Funds from the listing were utilised to eliminate approximately $13 million in debt, resulting in direct savings of around $1.4 million in annual costs.
FY25 Update
Revenue for FY25 to April 2025 reached $19.9 million with gross margins of $5.7 million. The performance was initially impacted by a slower start to the year due to stock outages, delivery delays of new products, and the IPO process. However, trade investment in the second half of FY25 returned to normal levels, boosting gross margins to around 37%.
Outlook
Wellnex expects continued growth throughout FY25 and into FY26, driven by increasing demand for its brands and products. The company is expanding distribution in Australia and preparing to enter the UK and European markets in FY26. IP licensing opportunities are growing, and the company aims to optimise trade investment and reduce operating expenses to enhance future performance.
Executive Comments
Joint CEO Director Zack Bozinovski stated, “We continue to see growth across the whole business in both brands and IP licensing opportunities and we are confident that this will continue, which we expect to enhance the future performance of the business. With the recent completion of the dual listing on the AIM Market and the removal of c. $13 million in liabilities, the Company is well positioned to take advantage of the opportunities in the growing consumer healthcare market.”
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
